Sector revisions Alkem Laboratories Limited Bombay S.E.

Stocks

Market Closed - Bombay S.E. 06:02:32 2026-09-22 EDT			5-day change	1st Jan Change
5,337.15 ^INR	-0.24%		+4.87%	-3.05%

09-16	Alkem Laboratories Limited Launches Neuceno for the Treatment of Partial-Onset Seizures in Adult Patients	CI
09-15	Alkem Laboratories Limited Announces Appointment of Shubhadeep Sinha to Senior Management Position, Effective September 15, 2026	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	4m. EPS revision	1y. EPS revision	Nbr of analysts
ELI LILLY AND COMPANY			29
JOHNSON & JOHNSON			22
ABBVIE INC.			28
ROCHE HOLDING AG			19
NOVARTIS AG			22
ASTRAZENECA PLC			23
AMGEN INC.			29
NOVO NORDISK A/S			23
GILEAD SCIENCES, INC.			27
PFIZER INC.			26
VERTEX PHARMACEUTICALS INCORPORATED			28
BRISTOL-MYERS SQUIBB COMPANY			24
SANOFI			24
GSK PLC			21
CHUGAI PHARMACEUTICAL CO., LTD.			15
TAKEDA PHARMACEUTICAL COMPANY LIMITED			16
BAYER AG			18
TEVA PHARMACEUTICAL INDUSTRIES LIMITED	-	-	2
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD			17
Average			22
Weighted average by Cap.			25